Women’s involvement in clinical trials: historical perspective and future implications
By Katherine Liu, N. D. Mager. 2016
382 citations recorded by the source corpus.
The importance of considering the differences between the male and female sex in clinical decision-making is crucial. However, it has been acknowledged in recent decades that clinical trials have not always adequately enrolled women or analyzed sex-specific differences in the data. As these deficiencies have hindered the progress of understanding women’s response to medications, agencies in the United States have worked towards the inclusion of women in clinical trials and appropriate analysis of sex-specific data from clinical trials. This review outlines the history and progress of women’s inclusion in clinical trials for prescription drugs and presents considerations for researchers, clinicians, and academicians on this issue.
Subfields: Gender Studies, Public Health, Environmental and Occupational Health, Medical & Health AI, Social Sciences & Humanities
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Social Sciences & Humanities
Citations in the corpus
- On preserving non-discrimination when combining expert advice (2018, background): “Another canonical example of sequential decision making is medical trials where underexploration on female groups often leads to significantly worse treatments for them [31].”